US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist
  • 1.160
  • +0.020+1.75%
Close May 2 16:00 ET
  • 1.179
  • +0.019+1.66%
Post 20:01 ET
19.50MMarket Cap-2.27P/E (TTM)

MIRA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-5.95%8.02M
-20.24%2.44M
-34.13%2.08M
78.38%1.73M
32.01%1.77M
20.97%8.53M
126.78%3.06M
74.75%3.16M
-59.92%970.22K
-8.96%1.34M
Selling and administrative expenses
-27.49%4.71M
-40.94%1.58M
-52.71%1.01M
4.20%1.12M
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
-General and administrative expense
-27.49%4.71M
-40.94%1.58M
-52.71%1.01M
4.20%1.12M
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
Research and development costs
110.15%3.31M
122.52%861.44K
5.14%1.07M
708.26%614.46K
180.66%762.28K
-33.11%1.57M
-56.25%387.12K
42.00%1.02M
-137.50%-101.02K
-43.30%271.61K
Other operating expenses
----
----
----
----
----
-73.39%453.55K
--0
----
----
20.98%453.55K
Operating profit
5.95%-8.02M
20.24%-2.44M
34.13%-2.08M
-78.38%-1.73M
-32.01%-1.77M
-20.97%-8.53M
-126.78%-3.06M
-74.75%-3.16M
59.92%-970.22K
8.96%-1.34M
Net non-operating interest income expense
104.79%165.67K
101.40%38.11K
108.83%37.75K
113.31%39.4K
3,149.97%50.42K
-33,619.94%-3.46M
-154,544.45%-2.73M
-18,440.62%-427.73K
-12,681.30%-295.89K
57.20%-1.65K
Non-operating interest income
----
----
----
--39.4K
----
----
----
----
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
12,681.30%295.89K
----
Total other finance cost
-104.79%-165.67K
-101.40%-38.11K
-108.83%-37.75K
----
-3,149.97%-50.42K
--3.46M
--2.73M
--427.73K
----
--1.65K
Other net income (expense)
Income before tax
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
Income tax
Net income
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
Net income continuous Operations
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
Minority interest income
Net income attributable to the parent company
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
Basic earnings per share
40.00%-0.51
62.50%-0.15
46.15%-0.14
-28.11%-0.11
-20.00%-0.12
-113.77%-0.85
-426.15%-0.4
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
Diluted earnings per share
40.00%-0.51
62.50%-0.15
46.15%-0.14
-28.11%-0.11
-20.00%-0.12
-113.77%-0.85
-426.15%-0.4
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -5.95%8.02M-20.24%2.44M-34.13%2.08M78.38%1.73M32.01%1.77M20.97%8.53M126.78%3.06M74.75%3.16M-59.92%970.22K-8.96%1.34M
Selling and administrative expenses -27.49%4.71M-40.94%1.58M-52.71%1.01M4.20%1.12M63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K
-General and administrative expense -27.49%4.71M-40.94%1.58M-52.71%1.01M4.20%1.12M63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K
Research and development costs 110.15%3.31M122.52%861.44K5.14%1.07M708.26%614.46K180.66%762.28K-33.11%1.57M-56.25%387.12K42.00%1.02M-137.50%-101.02K-43.30%271.61K
Other operating expenses ---------------------73.39%453.55K--0--------20.98%453.55K
Operating profit 5.95%-8.02M20.24%-2.44M34.13%-2.08M-78.38%-1.73M-32.01%-1.77M-20.97%-8.53M-126.78%-3.06M-74.75%-3.16M59.92%-970.22K8.96%-1.34M
Net non-operating interest income expense 104.79%165.67K101.40%38.11K108.83%37.75K113.31%39.4K3,149.97%50.42K-33,619.94%-3.46M-154,544.45%-2.73M-18,440.62%-427.73K-12,681.30%-295.89K57.20%-1.65K
Non-operating interest income --------------39.4K------------------------
Non-operating interest expense --------------------------------12,681.30%295.89K----
Total other finance cost -104.79%-165.67K-101.40%-38.11K-108.83%-37.75K-----3,149.97%-50.42K--3.46M--2.73M--427.73K------1.65K
Other net income (expense)
Income before tax 34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M
Income tax
Net income 34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M
Net income continuous Operations 34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M
Minority interest income
Net income attributable to the parent company 34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M
Basic earnings per share 40.00%-0.5162.50%-0.1546.15%-0.14-28.11%-0.11-20.00%-0.12-113.77%-0.85-426.15%-0.4-154.88%-0.2637.09%-0.08590.04%-0.1
Diluted earnings per share 40.00%-0.5162.50%-0.1546.15%-0.14-28.11%-0.11-20.00%-0.12-113.77%-0.85-426.15%-0.4-154.88%-0.2637.09%-0.08590.04%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Alibaba
BABA
125.760
Meta Platforms
META
597.020
Taiwan Semiconductor
TSM
179.280
4
Oracle
ORCL
150.730
5
ASML Holding
ASML
690.330
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.